FrancophonIA/ELRC3.0 huggingface dataset:
English: Severe, potentially life-threatening and fatal skin reactions have been reported with INCIVO combination treatment, including DRESS, SJS, and TEN (see section 4.4).
Slovenian: Pri zdravljenju z zdravilom INCIVO so poročali o hudih, lahko življenju nevarnih in smrtnih kožnih reakcijah, vključno s sindromom DRESS, SJS in TEN (glejte poglavje 4.4).
English: At the initiation and discontinuation of INCIVO treatment, doses of co-administered tacrolimus or cyclosporine A need to be markedly adjusted (see sections 4.4 and 4.5, Immunosuppressants).
Slovenian: Ob uvedbi in zaključku zdravljenja z zdravilom INCIVO je treba ustrezno prilagoditi odmerke sočasno uporabljenega takrolimusa ali ciklosporina A (glejte poglavji 4.4 in 4.5 Imunosupresivi).
English: Patients in these studies, 108, 111 and C216, had compensated liver disease, detectable HCV RNA, and liver histopathology consistent with chronic hepatitis C. Unless otherwise indicated, INCIVO was administered at a dosage of 750 mg every 8 hours (q8h); the peginterferon alfa-2a dose was 180 µg/week, and the ribavirin dose was 1,000 mg/day (patients weighing < 75 kg) or 1,200 mg/day (patients weighing ≥ 75 kg).
Slovenian: Bolniki v teh študijah (108, 111 in C216) so imeli kompenzirano jetrno bolezen, merljive vrednosti HCV RNK in histopatološki izvid jeter, ki je kazal na kronični hepatitis C. Če ni drugače navedeno, so ti bolniki prejemali zdravilo INCIVO v odmerku 750 mg na vsakih 8 ur, odmerek peginterferona alfa-2a je bil 180 µg/teden in odmerek ribavirina 1.000 mg/dan (za bolnike s telesno maso < 75 kg) ali 1.200 mg/dan (za bolnike s telesno maso ≥ 75 kg).
English: The highest documented INCIVO dose administered is 1,875 mg every 8 hours for 4 days in healthy volunteers.
Slovenian: Največji dokumentirani odmerek zdravila INCIVO, ki je bil dan pri zdravih prostovoljcih, je bil 1.875 mg na 8 ur, 4 dni.
English: - low blood platelet count, decrease in lymphocytes (a type of white blood cell), decrease in thyroid gland activity, increase in uric acid in your blood, decrease in potassium in your blood,
Slovenian: - nizko število krvnih ploščic, zmanjšanje števila limfocitov (vrsta belih krvničk), zmanjšano delovanje žleze ščitnice, povečanje vrednosti sečne kisline v krvi, zmanjšanje vrednosti kalija v krvi, povečanje vrednosti bilirubina v krvi
English: The resistance profile observed in Study HPC3008 in HCV/HIV-1 co-infected patients was similar to the resistance profile in mono-infected HCV patients.
Slovenian: Profil odpornosti opažen v študiji HPC3008 pri bolnikih s sočasno okužbo s HCV/HIV-1 je bil podoben profilu pri bolnikih, ki so bili okuženi samo s HCV.
English: Patients were randomised to 12 weeks of INCIVO (750 mg every 8 hours if taken in combination with atazanavir/ritonavir, tenofovir disoproxil fumarate, and emtricitabine or lamivudine OR 1,125 mg every 8 hours if taken in combination with efavirenz, tenofovir disoproxil fumarate, and emtricitabine) or placebo.
Slovenian: Bolnike so randomizirali na 12 tedensko zdravljenje z zdravilom INCIVO (750 mg na 8 ur v kombinaciji s shemo atazanavir/ritonavir, dizoproksiltenofovirat fumaratom in emtricitabinom ali lamivudinom ALI 1.125 mg na 8 ur v kombinaciji z efavirenzom, dizoproksiltenofovirat fumaratom in emtricitabinom) ali s placebom.
English: In one of those studies, a telaprevir 1,875 mg every 8 hours regimen was evaluated and the placebo-adjusted maximum mean increase in QTcF was 8.0 msec (90% CI: 5.1-10.9).
Slovenian: V eni od teh študij so ovrednotili shemo odmerjanja telaprevirja 1.875 mg na vsakih 8 ur in je največje srednje povečanje vrednosti QTcF, korigirano glede na placebo, znašalo 8,0 msek (90% IZ: 5,1-10,9).
English: TSH levels should be determined before and during the course of INCIVO combination treatment and treated as clinically appropriate, including potential adjustment of thyroid replacement therapy in patients with pre-existing hypothyroidism (see section 4.4,
Slovenian: Koncentracije TSH je treba določiti pred in med kombiniranim zdravljenjem z zdravilom INCIVO in ustrezno zdraviti, vključno z morebitnim prilagajanjem nadomestnega zdravljenja s ščitničnimi hormoni pri bolnikih z obstoječim hipotiroidizmom (glejte poglavje 4.4 Laboratorijske preiskave).
English: Telaprevir is approximately 59% to 76% bound to plasma proteins.
Slovenian: Telaprevir je približno 59% do 76% vezan na plazemske beljakovine, veže pa se predvsem na alfa-1 kisli glikoprotein in na albumin.
English: Moderate rash: Diffuse rash ≤ 50% of body surface area
Slovenian: Zmeren izpuščaj: difuzen izpuščaj ≤ 50 telesne površine
English: Because of the potential for adverse reactions in breastfed infants, due to the combined treatment of INCIVO with peginterferon alfa and ribavirin, breast-feeding must be discontinued prior to initiation of therapy.
Slovenian: Zaradi nevarnosti pojava neželenih učinkov pri dojenčkih zaradi kombiniranega zdravljenja s peginterferonom alfa in ribavirinom je treba pred uvedbo zdravljenja dojenje prekiniti.
English: • Rash and Severe Cutaneous Adverse Reactions safety data from Phases 2 and 3
Slovenian: • podatke o varnosti iz študij faze II in III o izpuščaju in hudih kožnih reakcijah
English: Increased clinical and laboratory monitoring are warranted (see section 4.4).
Slovenian: Potrebno je okrepljeno klinično in laboratorijsko spremljanje bolnika (glejte poglavje 4.4).
English: If indicated, elimination of unabsorbed active substance may be achieved by emesis or gastric lavage.
Slovenian: Če je to indicirano, lahko neabsorbirano zdravilno učinkovino odstranite iz telesa s sprožanjem bruhanja ali z izpiranjem želodca.
English: The overall safety profile of INCIVO is based on Phase 2 and 3 clinical trial data (both controlled and uncontrolled) containing 3,441 patients who received INCIVO combination treatment and on
Slovenian: Celokupni varnostni profil zdravila INCIVO temelji na podatkih iz kliničnih preskušanj faze II in III (nadzorovanih in nenadzorovanih), v katera je bilo vključenih 3.441 bolnikov, ki so prejemali kombinirano zdravljenje z zdravilom INCIVO in na spontanih poročilih iz obdobja trženja zdravila.
English: domperidone to treat vomiting and nausea (antiemetics)
Slovenian: domperidon za zdravljenje bruhanja in slabosti (antiemetiki)
English: INCIVO should be used with caution with Class Ic antiarrhythmics propafenone and flecainide, including appropriate clinical and ECG monitoring.
Slovenian: Pri bolnikih, ki jemljejo antiaritmika razreda Ic propafenon in flekainid je potrebna previdnost, vključno z ustreznim kliničnim spremljanjem in spremljanjem EKG.
English: ECG should be monitored at baseline and regularly during telaprevir treatment.
Slovenian: Pred začetkom in nato redno med zdravljenjem s telaprevirjem je treba spremljati EKG.
English: INCIVO, 1,125 mg (three 375 mg film-coated tablets) should be taken orally twice daily (b.i.d.)
Slovenian: Zdravilo INCIVO v odmerku 1.125 mg (tri 375 mg filmsko obložene tablete) je treba jemati peroralno dvakrat na dan, s hrano.
English: Suppression by telaprevir and VRT-127394 of CYP enzymes regulated via CAR, PXR and Ah nuclear receptors was observed in vitro in human hepatocytes.
Slovenian: V in vitro študijah na humanih hepatocitih so opazili s telaprevirjem in VRT-127394 povzročeno supresijo encimov citokroma, ki je bila regulirana preko jedrnih receptorjev CAR, PXR in Ah.
English: Fertility INCIVO had no effects on fertility or fecundity when evaluated in rats.
Slovenian: Zdravilo INCIVO ni vplivalo na plodnost ali rodnost pri podganah.
English: Increased dose of zolpidem may be required to maintain efficacy.
Slovenian: Za vzdrževanje učinka, bo morda potrebno zvečati odmerek zolpidema.
English: Co-administration of rifampicin with telaprevir is contraindicated.
Slovenian: Sočasna uporaba rifampicina s telaprevirjem je kontraindicirana.
English: HCV RNA levels should be monitored at weeks 4 and 12.
Slovenian: Koncentracijo HCV RNK je treba določati v 4. in 12. tednu.
English: INCIVO is a strong, time-dependent inhibitor of CYP3A4 and also markedly inhibits P-gp.
Slovenian: Zdravilo INCIVO je močan, časovno odvisen zaviralec encima CYP3A4, ki izrazito zavira tudi P-gp.
English: If a patient achieved undetectable HCV RNA (target not detected) at week 4, the total treatment duration was 24 weeks.
Slovenian: Če je po 4 tednih bolnik dosegel nezaznavno koncentracijo HCV RNK (nezaznaven analit), je zdravljenje trajalo 24 tednov.
English: INCIVO, in combination with peginterferon alfa and ribavirin, is indicated for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease (including cirrhosis):
Slovenian: Zdravilo INCIVO je v kombinaciji s peginterferonom alfa in ribavirinom indicirano za zdravljenje kroničnega hepatitisa C z genotipom 1 pri odraslih bolnikih s kompenzirano boleznijo jeter (vključno s
English: 3 and/or albumin < 3.3 g/dl.
Slovenian: 3 in/ali koncentracijo albumina < 33 g/l ni priporočena.
English: Mild and moderate CYP3A inducers should be avoided, particularly in patients who are prior non-responders (partial or null responders for peginterferon alfa/ribavirin), unless specific dose recommendations are given (refer to table 2).
Slovenian: Uporabi blagih in zmernih induktorjev CYP3A se je treba izogibati, še posebno to velja pri bolnikih, ki se predhodno niso odzvali na zdravljenje (bolniki z delnim odzivom in bolniki, ki se niso odzvali na zdravljenje s peginterferonom alfa/ribavirinom), razen, če so podana specifična priporočila za
English: Patients on an efavirenz-based regimen must receive INCIVO 1,125 mg every 8 hours.
Slovenian: Bolniki na osnovni shemi z efavirenzom morajo prejeti 1,125 mg zdravila INCIVO na 8 ur.
English: The Division of AIDS Table for Grading the Severity of Adult and Paediatric Adverse Events (DAIDS, version 1.0, December 2004) was used in the pooled laboratory datasets.
Slovenian: Pri združenih podatkih je bila uporabljena preglednica za ocenjevanje stopnje jakosti neželenih učinkov pri odraslih in pediatričnih bolnikih, imenovana The Division of AIDS (DAIDS, različica 1.0, december 2004).
English: Alternatively, 750 mg (two 375 mg tablets) can be taken orally every 8 hours (q8h) with food.
Slovenian: Zdravilo se lahko jemlje tudi po 750 mg (dve 375 mg tableti) peroralno na vsakih 8 ur, s hrano.
English: Co-administration of sildenafil or tadalafil and telaprevir in the treatment of pulmonary arterial hypertension is contraindicated (see section 4.3).
Slovenian: Sočasna uporaba sildenafila ali tadalafila (za zdravljenje pljučne arterijske hipertenzije) in telaprevirja je kontraindicirana (glejte poglavje 4.3).
English: If the HCV RNA concentration is > 1,000 IU/ml, INCIVO, peginterferon alfa, and ribavirin should be discontinued.
Slovenian: Če je koncentracija HCV RNK > 1.000 i.e./ml, je treba zdravljenje z zdravili INCIVO, peginterferon alfa, in ribavirin ukiniti.
English: INCIVO is available in packs containing 1 bottle (total of 42 film-coated tablets) or 4 bottles (total of
Slovenian: Zdravilo INCIVO je na voljo v škatli z 1 plastenko (vsebuje 42 filmsko obloženih tablet) ali v škatli s 4 plastenkami (skupaj 168 filmsko obloženih tablet).
English: INCIVO is available in packs containing one bottle or 4 bottles per carton.
Slovenian: Zdravilo INCIVO je na voljo v škatlah, ki vsebujejo 1 ali 4 plastenke.
English: Patients taking INCIVO frequently get an itchy skin rash.
Slovenian: Pri bolnikih, ki jemljejo zdravilo INCIVO se pogosto pojavi srbeč kožni izpuščaj.
English: Excipient: 2.3 mg of sodium per film-coated tablet.
Slovenian: Pomožna snov: 2,3 mg natrija na filmsko obloženo tableto
English: Paseo de las Doce Estrellas, 5-7 E-28042 Madrid
Slovenian: Paseo de las Doce Estrellas, 5-7 E-28042 Madrid Tel: +34 91 722 81 00
English: ↑ triazolam inhibition of CYP3A
Slovenian: ↑ triazolam zaviranje CYP3A
English: The overall safety profile of INCIVO in HCV/HIV-1 co-infected patients (either not on antiretroviral therapy or on antiretroviral therapy) was similar to the safety profile in mono-infected HCV patients, except for patients receiving atazanavir/ritonavir who frequently experienced a transient increase in indirect bilirubin levels (including grades 3 to 4) through week 2, returning to near baseline by week 12 (see section 4.4).
Slovenian: Celokupni varnostni profil zdravila INCIVO pri bolnikih s sočasno okužbo s HCV/HIV-1 (ki ne prejemajo ali prejemajo protiretrovirusna zdravila) je bil podoben varnostnemu profilu pri bolnikih, okuženih samo s HCV. Razlikoval se je samo pri skupini bolnikov, ki so prejemali atazanavir/ritonavir, kjer je v 2. tednu pogosto prišlo do prehodnega zvečanja koncentracije indirektnega bilirubina (stopnje 3 do 4), ki pa se je do 12. tedna vrnila skoraj na izhodiščno vrednost (glejte poglavje 4.4).
English: To prevent treatment failure, the dose of INCIVO must not be reduced or interrupted.
Slovenian: Za uspešno zdravljenje, ne smete zmanjšati ali odložiti odmerka zdravila INCIVO.
English: Haematology evaluations (including white cell differential count) are recommended at weeks 2, 4, 8
Slovenian: Hematološke preiskave (vključno z diferencialno belo krvno sliko) so priporočene v 2., 4., 8. in 12. tednu in kot je klinično primerno.
English: Additional methods of non-hormonal contraception should be used when hormonal contraceptives are co-administered with telaprevir.
Slovenian: Pri sočasni uporabi hormonskih kontraceptivov s telaprevirjem je treba uporabljati dodatne nehormonske kontracepcijske metode.
English: INCIVO was given for the first 8 weeks of treatment (T8/PR regimen) or the first 12 weeks of treatment (T12/PR regimen) in combination with peginterferon alfa-2a and ribavirin for either 24 or 48 weeks.
Slovenian: Zdravilo INCIVO so jim dajali v prvih 8 tednih zdravljenja (shema T8/PR) ali v prvih 12 tednih zdravljenja (shema T12/PR), v kombinaciji s peginterferonom alfa-2a in ribavirinom bodisi za 24 ali 48 tednov.
English: to treat schizophrenia, bipolar disorder and major depressive disorder midazolam (taken by mouth), triazolam (taken to help you sleep and/or relieve anxiety (sedatives/hypnotics)
Slovenian: za zdravljenje shizofrenije, bipolarne motnje in velike depresije midazolam (zaužit skozi usta), triazolam (zaužit za lažje spanje in/ali za lajšanje tesnobe (sedativi/hipnotiki) za zdravljenje epileptičnih napadov (antikonvulzivi)
English: Concomitant administration with active substances that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events.
Slovenian: Sočasna uporaba z zdravilnimi učinkovinami, ki se v veliki meri presnavljajo z izoencimom CYP3A in pri katerih so zvišane plazemske koncentracije lahko povezane z resnimi in/ali življensko nevarnimi neželenimi učinki.
English: Table 14: Pooled response rates: Study C208
Slovenian: Preglednica 14: skupna stopnja virološkega odziva: študija C208
English: Patients taking INCIVO may develop a skin rash.
Slovenian: Pri bolnikih, ki jemljejo zdravilo INCIVO, se lahko pojavi kožni izpuščaj.
English: Results of a study conducted in healthy volunteers demonstrated a modest effect of telaprevir at a dose of 1,875 mg every 8 hours on the QTcF interval with a placebo-adjusted maximum mean increase of 8.0 msec (90% CI: 5.1-10.9) (see section 5.1).
Slovenian: Izsledki študije pri zdravih prostovoljcih, so pokazali majhen vpliv telaprevirja na interval QTcF pri odmerku 1.875 mg na 8 ur, pri čemer je bila največja srednja vrednost tega povečanja, korigirana glede na placebo, 8,0 msek (90% IZ: 5,1-10,9) (glejte poglavje 5.1).
English: INCIVO in combination with peginterferon and ribavirin is not recommended in patients with platelets < 90,000/mm
Slovenian: Uporaba zdravila INCIVO v kombinaciji s peginterferonom in ribavirinom pri bolnikih s številom trombocitov < 90.000/mm
English: Tacrolimus may prolong the QT interval (see section 4.4).
Slovenian: Takrolimus lahko podaljša interval QT (glejte poglavje 4.4).
English: INCIVO 375 mg film-coated tablets telaprevir
Slovenian: INCIVO 375 mg filmsko obložene tablete telaprevir
English: SVR rates for the T12(DS)/PR group were 88% (124/141) for prior relapsers, 56% (27/48) for prior partial responders, and 33% (25/75) for prior null responders.
Slovenian: Stopnje trajnega virološkega odziva za skupino T12(DS)/PR so bile naslednje: 88% (124/141) za bolnike, ki so imeli predhodno ponovitev bolezni, 56% (27/48) za tiste, ki so se prej delno odzvali na zdravljenje, in 33% (25/75) za tiste, ki se prej niso odzvali na zdravljenje.
English: Each film-coated tablet contains 375 mg of telaprevir.
Slovenian: Ena filmsko obložena tableta vsebuje 375 mg telaprevirja.
English: abacavir, efavirenz, tenofovir disoproxil to treat HIV infections (reverse transcriptase inhibitors) to lower cholesterol levels (HMG CoA reductase inhibitors) all types of hormonal contraceptives (‘the pill') hormonal contraceptives hormone replacement therapy to lower your immune system (immunosuppressants), medicines used in some rheumatic diseases or to avoid problems with organ transplants to improve breathing for asthma (inhaled beta agonists) to treat type II diabetes (blood glucose lowering medicine) for the treatment of opioid (narcotic) dependence to treat erectile dysfunction or to treat a heart and lung disorder called pulmonary arterial hypertension (PDE-5 inhibitors)
Slovenian: abakavir, efavirenz, dizoproksiltenofovirat za zdravljenje okužbe s HIV (zaviralci reverzne transkriptaze) fluvastatin, pitavastatin, pravastatin, rosuvastatin za zniževanje koncentracije holesterola (zaviralci reduktaze HMG CoA hormonski kontraceptivi hormonska nadomestna terapija za zaviranje imunskega sistema (imunosupresivi), zdravila, ki se uporabljajo pri nekaterih revmatskih boleznih ali v izogib težav pri presaditvi organov za lažje dihanje (inhalacijski agonisti adrenergičnih receptorjev beta) za zdravljenje sladkorne bolezni tipa II (zdravilo za zniževanje koncentracije sladkorja v krvi) za zdravljenje odvisnosti od opioidov za zdravljenje motenj erekcije ali srčne in pljučne bolezni, imenovane pljučna arterijska hipertenzija (zaviralci PDE-5)
English: C-telaprevir in healthy subjects, 90% of total radioactivity was recovered in faeces, urine and expired air within 96 hours post-dose.
Slovenian: označenega telaprevirja pri zdravih bolnikih so v blatu, seču in izdihanem zraku izmerili 90% skupne radioaktivnosti v času 96 ur po zaužitju odmerka.
English: In the Phase 3 studies, none of the patients with HCV RNA > 1,000 IU/ml at either week 4 or week 12 achieved SVR with continued peginterferon alfa and ribavirin treatment.
Slovenian: V študijah faze III, nobeden izmed bolnikov, ki so v 4. ali 12. tednu imeli koncentracijo HCV RNK > 1.000 i.e./ml, v nadaljevanju zdravljenja s peginterferonom alfa in ribavirinom ni dosegel SVR.
English: Transporters In vitro studies demonstrated that telaprevir is an inhibitor of OATP1B1 and OATP2B1.
Slovenian: In vitro študije so pokazale, da telaprevir zavira prenašalca OATP1B1 in OATP2B1.
English: Patients were required to have an HIV-1 RNA < 50 copies/ml
Slovenian: Bolniki so morali imeti na presejalnem pregledu < 50 kopij RNK HIV-1/ml, število celic CD4 ≥ 300 celic/mm
English: Replicons with single substitutions at position 155 or 156 and double variants with substitutions at residues 36 and 155 showed cross-resistance to all protease inhibitors tested with a wide range of sensitivities.
Slovenian: Pri variantah, rezistentnih na telaprevir, so testirali navzkrižno rezistenco proti reprezentativnim zaviralcem proteaze v sistemu replikonov HCV. Replikoni z eno samo substitucijo na mestu 155 ali 156 in dvojne variante s substitucijami na ostankih 36 in 155 so pokazale navzkrižno rezistenco za vse testirane zaviralce proteaze s širokim razponom občutljivosti.
English: (< 2.0 mEq/l)
Slovenian: (< 2,0 mmol/l)
English: Table 15 shows the response rates for the T12/PR48 and the Pbo/PR48 arms.
Slovenian: V preglednici 15 so prikazane stopnje odziva za kraka T12/PR48 in Pbo/PR48.
English: - Adequately controlled thyroid function (TSH) - Calculated creatinine clearance ≥ 50 ml/min
Slovenian: - absolutno število nevtrofilcev ≥ 1.500/mm - zadosten nadzor delovanja ščitnice (TSH) - izračunan očistek kreatinina ≥ 50 ml/min
English: In placebo-controlled Phase 2 and 3 trials, 0.4% of patients had suspected Drug Rash with Eosinophilia and Systemic Symptoms (DRESS).
Slovenian: V s placebom nadzorovanih preskušanjih faze II ali III je imelo 0,4% bolnikov sum na medikamentozni izpuščaj z eozinofilijo in sistemskimi simptomi (sindrom DRESS).
English: No specific antidote is available for overdose with INCIVO.
Slovenian: Za preveliko odmerjanje zdravila INCIVO ni specifičnega antidota.
English: ↑ alprazolam AUC 1.35 (1.23-1.49) Cmax 0.97 (0.92-1.03)
Slovenian: ↑ alprazolama AUC 1,35 (1,23-1,49) Cmax 0,97 (0,92-1,03)
English: In treatment-naïve patients in the Phase 3 studies, 4/16 (25%) patients with HCV RNA levels between 100 IU/ml and 1,000 IU/ml at week 4 achieved SVR.
Slovenian: V študijah faze III pri bolnikih, ki še niso bili zdravljeni, so 4/16 (25%) bolniki s koncentracijami HCV RNK med 100 i.e./ml in 1.000 i.e./ml v 4. tednu dosegli SVR.
English: If you are taking any of the above, ask your doctor about switching to another medicine.
Slovenian: Če jemljete katerokoli izmed naštetih zdravil, prosite zdravnika, da vam ga zamenja z drugim.
English: Janssen Cilag International NV
Slovenian: Janssen Cilag International NV Turnhoutseweg 30
English: If improvement is not observed within 7 days of INCIVO discontinuation, sequential or simultaneous interruption or discontinuation of ribavirin and/or peginterferon alfa should be considered.
Slovenian: Če se izpuščaj v 7 dneh po ukinitvi zdravila INCIVO ne izboljša bo lahko potrebna tudi postopna ali sočasna prekinitev zdravljenja s peginterferonom alfa in/ali ribavirinom.
English: When administered every 8 hours (q8h), in case a dose of INCIVO is missed within 4 hours of the time it is usually taken, patients should be instructed to take the prescribed dose of INCIVO with food as soon as possible.
Slovenian: Jemanje zdravila na osem ur: v primeru, da bolnik pozabi vzeti odmerek zdravila INCIVO do 4 ure po času, ko ga običajno jemlje, mu naročite, naj čimprej vzame predpisani odmerek zdravila INCIVO s hrano.
English: Refer also to the Summary of Product Characteristics for peginterferon alfa and ribavirin which are contraindicated in Child-Pugh score ≥ 6.
Slovenian: Preberite tudi Povzetek glavnih značilnosti zdravil peginterferon alfa in ribavirin, ki sta pri bolnikih z oceno ≥ 6 po Child-Pughu kontraindicirana.
English: INCIVO should be used with caution with Class Ic antiarrhythmics propafenone and flecainide, including appropriate clinical and ECG monitoring (see section 4.4).
Slovenian: Pri bolnikih, ki jemljejo antiaritmika razreda Ic propafenon in flekainid je potrebna previdnost, vključno z ustreznim kliničnim spremljanjem in spremljanjem EKG (glejte poglavje 4.4).
English: The frequency rate of the side effects associated with INCIVO is given below.
Slovenian: Stopnje pogostnosti neželenih učinkov, povezanih z zdravilom INCIVO so navedene v nadaljevanju.
English: For all populations in the study (prior relapsers, prior partial responders, and prior null responders), SVR rates were higher for the T12/PR group than for the Pbo/PR48 group across subgroups by sex, age, race, ethnicity, body mass index, HCV genotype subtype, baseline HCV RNA level, and extent of liver fibrosis.
Slovenian: Pri vseh populacijah v tej študiji (pri bolnikih, ki so imeli predhodno ponovitev bolezni, bolnikih, ki so se prej delno odzvali na zdravljenje, in bolnikih, ki se prej niso odzvali nanj), so bile stopnje trajnega virološkega odziva večje v skupini T12/PR kot v skupini Pbo/PR48 po podskupinah glede na spol, starost, raso, etnično pripadnost, indeks telesne mase, podtip genotipa HCV, začetne vrednosti HCV RNK in obseg jetrne fibroze.
English: These can be seen in the results from blood tests.
Slovenian: Vse to bo izvedel iz izvidov preiskav krvi in vam pojasnil.